cant difference, being significantly lower in the CRLZ group Is low plasma 25-(OH)vitamin D a major risk factor for hyper-(26 Ϯ 18 vs. 57 nmol/liter, ANOVA, P Ͻ 0.004). Plasma parathyroidism and Looser's zones independent of calcitriol?
D status of their patients [1, 2] . 1␣-Hydroxylated derivameasurements of the patients with CRLZ were compared with tives of vitamin D are widely used in the dialysis patients those from patients without radiological lesions, plasma of Western countries, but how many renal physicians mea-25OHD was the only parameter to show a statistically signifisure the plasma 25-(OH)vitamin D (25OHD)? There is a further assumption that plasma calcitriol levels are independent of commonly prevailing levels of 25OHD [3] .
on the synthesis of calcitriol by monocytes and macrophages in which the 1-hydroxylase activity is less tightly regulated than in the kidney tubule [1] . The assumption dialysis population in which conditions were far from ideal. The dialysis conditions were poor, and aluminumthat 1␣-hydroxylated metabolites are the only active forms containing phosphate binders, calcium salts, and all of vitamin D and the knowledge that large doses of precurforms of vitamin D-parent, 25-hydroxylated, and sormin D are needed to increase the production of 1-hydroxylated-were available only intermittently. calcitriol have led to a general abandonment of traditional forms of vitamin D in favor of the 1␣-hydroxylated forms. This trend has been encouraged by the knowledge METHODS that any unintended hypercalcemia is much more easily Patients reversible than with parent vitamin D [6] .
One hundred and thirteen uremic patients (54 men These assumptions have now been challenged [reand 59 women) maintained on chronic hemodialysis at viewed in 2], and recent epidemiological studies have the Annaba University Hospital were included in the shown a high prevalence of low 25OHD levels in older study. Their mean age was 39 Ϯ 12 years, and their mean healthy ambulant Europeans [7] , Parisian neonates [8] , duration on dialysis was 44 Ϯ 34 months. All patients Spanish children in winter [9] , and unselected medical were dialyzed for six hours twice per week. As verified in-patients in New England (USA) [10] . In the last group, by chemical analysis, the dialysate concentration (mmol/ the most important discriminator for low 25OHD levels liter) was 1.75 for calcium, 0.75 for magnesium, and 35 was whether the patients were on any form of dialysis.
for acetate. The water used for the dialysate was treated These individuals had hypovitaminosis D of a degree by reverse osmosis and contained less than 0.2 mol/ less than that associated with osteomalacia. They were liter of aluminum. not symptomatically deficient in vitamin D, but there Most patients were prescribed oral calcium salts and was not enough vitamin D to prevent the release of aluminum-containing phosphate binders; however, beregulating hormones such as parathyroid hormone cause of the limited market availability and cost, compli-(PTH) and calcitriol, and seasonal change in bone denance was poor. At the time the blood samples were sity. Classic vitamin D deficiency in association with ostaken, for example, only one half of the patients were teomalacia (in the absence of renal failure) usually corretaking their prescribed drugs. Vitamin D compounds, sponds with 25OHD levels well below the lower limit of including alphacalcidol and calcitriol, were not prethe reference population in western Europe, that is, 8 scribed at all. to 10 ng/ml (20 to 25 nmol/liter) [35] . "Vitamin D insuffiDietary assessment by a dietitian revealed the mean ciency," on the other hand, has been defined by the protein intake to be 45 g (range 20 to 112, part vegetable plasma 25OHD being below various thresholds, all and part animal). The mean calcium intake was 428 mg higher than those levels associated with classic defi-(range 200 to 1000), and the intake of phosphate was ciency, as follows: 12 ng/ml (30 nmol/liter) [7] [8] [9] or 15 700 mg (range 300 to 1500). ng/ml (37.5 nmol/liter) [10], based on the point at which PTH secretion is stimulated; 20 ng/ml (50 nmol/liter), Radiological assessment based on the level below which plasma calcitriol depends All patients had a plain x-ray of the hands and pelvis on plasma 25OHD [9]; or even 40 ng/ml (100 nmol/liter), in the three months before biochemical evaluation. The which is the level above that in Boston (MA, USA) when x-rays were independently assessed by a nephrologist the seasonal variation in plasma PTH and bone mass in and a rheumatologist. The hand x-rays were examined healthy postmenopausal women is abolished [11] .
for evidence of hyperparathyroidism, as manifested by In patients with renal failure, PTH secretion, calcitriol subperiosteal resorption along the radial border of the synthesis, and bone mineral density are influenced by a phalanges, and the superior and inferior pubic rami, as number of factors independently of plasma 25OHD levwell as femoral necks, were examined for overt evidence els and secondary to the uremic state. Therefore, these of osteomalacia, that is, Looser's zones. In the event of pathophysiological definitions are probably irrelevant in disagreement between the two assessors, a radiologist's dialysis patients. On the other hand, it is important to opinion was sought. Neither assessor had any knowledge try to establish the role of plasma 25OHD in uremic of the biochemical results. patients for both PTH hypersecretion and the genesis of Biochemical evaluation renal bone disease, independently of other known risk factors including calcitriol, and the optimal range of Blood samples were taken from the patients just beplasma 25OHD, that is, the range associated with the fore they started their first dialysis of the week, which lowest incidence of radiological bone lesions and lowest was during the month of September. The samples were plasma PTH concentrations.
centrifuged at once and stored at Ϫ20ЊC. Later, as a It was important, therefore, to study a dialysis populabatch, they were encased in cryogel and taken by air to tion in which the prevalence of radiological bone disease Amiens, France for analysis.
The following measurements were made: plasma conwas likely to be high. We have studied an Algerian hemo- The determinants of plasma PTH were assessed by univariate analysis with linear regression and by multivarimeasured by a two-site immunochemiluminometric method [12] using two specific antibodies (normal range ate analysis with multiple regression. The determinants of the radiological lesions were first assessed by the chiof 1.1 to 5.5 pmol/liter; Ciba Corning, Essex, UK). Plasma concentrations of aluminum were measured by square method for qualitative parameters and by a factorial analysis of variance for quantitative ones, with the inductively coupled plasma emission spectrometry (normal is less than 0.35 mol/liter) [13]. The plasma concenlevel of significance of the multicomparison being 95% (P Ͻ 0.05). When several factors were found to be linked tration of 25OHD and calcitriol was measured by radiocompetition methods [reference range for 25OHD in to the presence of a radiological lesion, logistical regression was used to identify the independent determinant. Paris in the late summer was 25 to 100 nmol/liter (10 to
RESULTS

Assessment of plasma 25OHD as an independent determinant of plasma parathyroid hormone
The median plasma 25OHD was 47.5 nmol/liter (range 2.5 to 170.0) and was comparable in men and women. The plasma PTH concentration was positively correlated with the duration on dialysis and negatively with the plasma concentration of calcium, bicarbonate, 25OHD, calcitriol, and aluminum but not correlated with that of phosphate ( Table 1) . It is noteworthy that the correlation was closer with plasma 25OHD than with plasma calcitriol (r ϭ Ϫ0.32 vs. Ϫ0.19, with a P value of 0.001 vs. 0.05; Table 1) .
A multiple regression analysis of plasma PTH concentration was performed with the same parameters used in 25OHD represents the threshold at which seasonal variations of hip bone density is abolished (Boston) [12] . N ϭ 103; r ϭ 0.32; P ϭ 0.001.
Prevalence of radiological bone lesions
The radiological survey showed subperiosteal resorption in 38 patients and Looser's zones in 10 ( Table 2) .
The only statistically significant difference between the For evaluation of risk factors for these bone lesions, the group with Looser's zones (group III) and the two other patients were subdivided into three groups: group I, no groups was the lower plasma 25OHD [26 vs. 57 (group I) bone lesions (N ϭ 65, 57%); group II, subperiosteal and 44 (group II) nmol/liter]. resorption alone (N ϭ 38, 34%); group III, both subperiosteal resorption and Looser's zones (N ϭ 10, 9%).
Suggestions as to the optimal range for plasma 25OHD Assessment of plasma 25OHD as a risk factor for radiological bone lesions Figure 1 shows individual plasma 25OHD measurements subdivided by radiological groups. Looser's zones The three radiological groups defined previously here (always associated with subperiosteal resorption) did not were comparable in age, gender, and duration on dialysis.
occur with plasma 25OHD of more than 40 nmol/liter, Plasma PTH concentrations and alkaline phosphatases and subperiosteal resorption did not occur with plasma were elevated in all three groups, being significantly 25OHD of more than 100 nmol/liter. higher in groups II and III than in the "no-lesion" group, Figure 2 shows the regression of plasma PTH against but not significantly different between groups II and plasma 25OHD. The two horizontal dotted lines delin-III. Plasma calcium and bicarbonate concentrations were eate the optimal range (10.0 to 25.0 pmol/liter) proposed lower in the two groups with bone lesions than in the by Wang et al in hemodialysis patients moderately overno-lesion group, but the difference was significant only loaded with aluminum (positive aluminon staining befor the group with isolated subperiosteal resorption tween 0 and 24%) in order to have a normal bone forma-(ISR). There was no significant difference between the tion rate [16] . All patients with plasma PTH above the groups with and without lesions in the plasma concentraupper limit of this optimal range had a plasma 25OHD tions of calcitriol, phosphate, and aluminum.
of less than 100 nmol/liter. Conversely, in all patients The mean plasma 25OHD (nmol/liter) was lower in with a plasma 25OHD of more than 100 nmol/liter, the two groups with bone lesions compared with the plasma PTH was close to the optimal range. group without lesions. Logistical regression analysis in- Figure 3 shows regression of plasma Ca against plasma cluded age, duration on dialysis, and all biochemical pa-25OHD. Hypercalcemia above 2.70 mmol/liter was presrameters measured in order to evaluate any independent ent in only one case when plasma 25OHD was above association between plasma 25OHD and subperiosteal 100 nmol/liter. The corresponding value of plasma resorption. No independent association was found with 25OHD was 140 nmol/liter, whereas that of calcitriol plasma 25OHD, but there was an association between subperiosteal resorption and plasma PTH (P Ͻ 0.001).
was only 80 pmol/liter and that of plasma PTH was 5.5 centrations were only weakly correlated with those of PTH and showed no link with Looser's zones. Subperiosteal resorption has sometimes been associated with aluminum-induced osteomalacia, even when histologically there is no active hyperparathyroidism. The explanation is probably that resorption cavities of past hyperparathyroidism become filled with osteoid that cannot calcify, so the histological (and radiological) abnormalities remain until the aluminum toxicity has been treated. In our patients, the mean plasma aluminum of those with Looser's zones was 0.95 mol/liter, that is, mildly raised, but not high enough to be associated with histological toxicity according to the data of Pei et al [20] . Our patients were unlikely to have aluminum bone were not suppressed below 20 pmol/liter. Therefore, in our patients the presence of phalangeal subperiosteal resorption in association with Looser's zones was on the basis of vitamin D deficiency osteomalacia in association pmol/liter. Hypercalcemia of 2.7 to 3.4 mmol/liter was, with hyperparathyroidism, and not on the basis of alumihowever, present in eight cases, with a plasma 25OHD num-induced osteomalacia. ranging from 15 to 100 nmol/liter, with normal plasma calcitriol in all cases but one (180 pmol/liter). Plasma Low vitamin D status as a risk factor for PTH was less than 10 pmol/liter in five patients and hyperparathyroidism independent of calcitriol between 30 and 130 pmol/liter in three of these hypercalSubperiosteal resorption is the radiological manifestacemic patients.
tion of histological osteitis fibrosa related to high plasma PTH levels, as has already been established by clinical DISCUSSION and experimental studies [1] . It is therefore not surprising that plasma PTH emerged as the sole independent correAny radiological evaluation will underestimate the late associated with subperiosteal resorption in the logisprevalence of renal bone disease [17] because it is known tic regression. The negative correlation between plasma that, although 90 to 100% of patients with end-stage 25OHD and plasma PTH is rather more surprising and, renal disease have histological evidence of renal osteoas far as we are aware, has not been reported before in dystrophy, only 25 to 30% have evidence of subperiosteal hemodialysis patients. Bayard et al, who first reported resorption [18] . Nevertheless, despite the relative youth plasma levels of 25OHD in uremic patients prior to and (39 years) of the hemodialysis patients described here while on maintenance dialysis, only pointed to a positive and the short time on dialysis (44 months), we have correlation between plasma 25OHD and plasma calcium found a large proportion of patients with radiological levels [21] . The correlation that we observed between bone lesions (48 out of 113; 42.5%), 10 of whom had plasma 25OHD and plasma PTH suggests either that Looser's zones. This high prevalence of radiological bone high plasma PTH levels decrease 25OHD or, alternadisease in Annaba is reminiscent of what was observed tively, that 25OHD, either directly or indirectly, has a when chronic dialysis first became available in Western suppressive effect on PTH secretion. countries [19] and was anticipated as a likely conseThe possibility that high plasma PTH levels decrease quence of underdialysis in combination with relative unplasma 25OHD levels should be considered because in availability and high cost of appropriate therapeutic primary hyperparathyroidism, there is an increased metagents.
abolic clearance of 25OHD due to an increased excretion One important finding is that low plasma 25OHD was of vitamin d-derived inactive products in the feces, which closely associated with the presence of Looser's zones is reversed by surgical parathyroidectomy [22] ; this and, furthermore, that plasma 25OHD was indepenmechanism accounts much better by far for the developdently and negatively correlated with plasma PTH. This ment of vitamin D deficiency in this disease than the combination of statistical associations strongly suggests increased transformation of 25OHD 3 into calcitriol [23] . that vitamin D insufficiency is at least partly responsible There is, however, no evidence from animal studies that for both the Looser's zones and the hyperparathyroideither calcium or PTH has direct independent effects on the hepatic metabolism of 25OHD [24, 25] , whereas ism. Interestingly, and in contrast, plasma calcitriol con-these studies demonstrate that calcitriol increases the than calcitriol by a factor of only 500 rather than 2400 [29] . Because its circulating concentration is 1000-fold metabolic clearance of 25OHD and the biliary excretion of its degradation metabolites. Furthermore, there is evithat of calcitriol, a physiological role for 25-OHvitamin D independent of calcitriol is eminently possible. Indence in humans that calcitriol, but not PTH directly, is operative in the decrease of 25OHD half-life in hyperdeed, comparing the molar potency ratio of 25-OH vitamin D with that of calcitriol for producing a 25% parathyroidism [26] . Indeed, the 25OHD half-life was increased in a patient with intestinal malabsorption when increase of calcium absorption in healthy humans in whom 25-OHvitamin D 3 did not increase plasma calcilarge calcium supplements suppressed his secondary hyperparathyroidism and decreased calcitriol levels, whereas triol levels, Heaney et al found it to be approximately 1:100 [30] . These authors concluded that physiological in patients with postmenopausal osteoporosis, the oral administration of 1 g of calcitriol for four days shortplasma 25OHD levels can, on their own, account for one-eighth of the ability to absorb calcium from the gut. ened this half-life and decreased the plasma 25OHD levels. Because the mean plasma calcitriol levels in our An alternative explanation for the independent negative correlation between plasma PTH and plasma patients on dialysis who received no calcitriol were near the lower range of normal, and because their plasma 25OHD is displacement of free calcitriol from vitamin D-binding protein when plasma 25OHD increases. The calcitriol levels were negatively correlated to their plasma PTH levels but positively correlated to their finding of raised free calcitriol levels in patients with vitamin D intoxication has been reported by Pettifor et plasma 25OHD levels, it is most unlikely that their endogenous calcitriol could contribute significantly to the al [31] ; however, in their cases the plasma 25OHD levels were between 850 and 1650 nmol/liter, which is much decrease of their plasma 25OH levels.
Therefore, the alternative causal relationship is more higher than in our patients (all had plasma 25OHD values below 170 nmol/liter). Therefore, such a phenomelikely, and we now discuss its possible mechanisms. Because plasma 25OHD was positively correlated with calnon is unlikely to explain the findings in our study. Finally, a possible beneficial effect of relatively high cium and calcitriol, the negative correlation between plasma 25OH and PTH could be explained by the known 25OHD levels on bone resorption is greater availability of substrate for 24-hydroxylase, leading to higher plasma independent suppressive effects of calcitriol and calcium on PTH synthesis [27] . However, multiple regression 24,25-(OH) 2 D levels [4] . It has been shown by Popovtzer et al that 24,25-(OH) 2 D decreases bone resorption in analysis showed that the negative correlation between plasma 25OHD and plasma PTH was independent of dialysis patients independently of calcitriol [32] . This effect could result either from a direct action on bone the plasma concentrations of calcium and calcitriol, and indeed of those of phosphate and aluminum. This indeor, alternatively, by contributing to a decrease in PTH secretion because it is known that pharmacological doses pendent negative correlation of plasma 25OHD with plasma PTH in hemodialysis patients is in agreement of 24,25-(OH) 2 D 3 cause a fall in PTH levels both in dialysis patients [33] and in patients with X-linked hypowith the negative association between plasma 25OHD on one hand and plasma PTH and pyridinolinuria (a phosphatemic osteomalacia [34] . marker of bone resorption) on the other hand [28] , which Low vitamin D status as a risk factor for osteomalacia was recently found in a cross-sectional study of older men admitted for hip fracture, independent of plasma In patients maintained on chronic hemodialysis, the most likely cause of clinical osteomalacia is aluminum free calcitriol and free testosterone. These findings suggest an effect of 25OHD (or of its metabolites other than intoxication, whether acquired from aluminum-containing phosphate binders or from an inadequately prepared wacalcitriol) on PTH secretion either directly or indirectly by potentiating the effect of calcitriol.
ter supply. We have already shown that aluminum is unlikely to be etiologically relevant to the development of Such a hypothesis challenges the currently prevailing concept that calcitriol is the sole active vitamin D metabradiological bone lesions of our patients. Other hypothetically important etiological possibilities are hypocalolite that promotes intestinal absorption of calcium and phosphate and down-regulates the transcriptional step cemia and acidosis. In this study, there was no statistically significant difference in the plasma calcium and bicarof PTH synthesis. Indeed, because the affinity of calcitriol for vitamin D receptor is 2400-fold higher than that bonate between the two abnormal bone groups and the group with no radiological abnormality. Clearly, howof 25OHD, the 1000-times higher physiological plasma levels of 25OHD are theoretically unable to exert any ever, the cross-sectional design of the study and the lack of sensitivity of bone radiology mean that it is not possisignificant biological effect on their own [1, 2] . However, recent basic research has revealed a potential physiologible to definitively rule out hypocalcemia, acidosis, or even mild aluminum overload as etiologically relevant. cal role for 25-OHvitamin D itself, independent of calcitriol. In a whole cell transcriptional activation system, Qaw
This does not diminish the value of our finding that the one biochemical parameter to show a statistical differet al have shown that 25-OHvitamin D was less effective ence between groups was plasma 25OHD, which was above which Looser's zones do not develop. The level above which patients did not have Looser's zones was lower in the group with Looser's zones (26 nmol/liter) than in either the group with subperiosteal resorption 40 nmol. Because the group with superiosteal resorption on hand x-rays but without Looser's zones also had low alone (44 nmol/liter) or the group without any radiological lesions (57 nmol/liter). In other words, plasma 25OHD levels (but not as low as the Looser's zones group), it is possible that the threshold for suppression 25OHD emerges as the main risk factor for radiological osteomalacia in these hemodialysis patients.
of hyperparathyroidism is rather higher. For example, no patient with a plasma 25OHD of more than 100 nmol/ The role of vitamin D deficiency in the pathogenesis of osteomalacia in patients with chronic renal failure liter had radiological evidence of subperiosteal resorption. Interestingly, this is the same level required to pre-(not on dialysis) was suggested by Eastwood et al, who reported low plasma 25OHD (less than 30 nmol/liter) vent the seasonal variation of PTH and hip mineral density loss in healthy postmenopausal women [12] . in patients with histologic osteomalacia compared with those with normal bones or histological hyperparathyAll of the hemodialysis patients with a plasma 25OHD of more than 100 nmol/liter had a plasma PTH close to roidism alone [35] . Memmos et al showed that the bones of such patients could be cured with physiological doses the optimal range proposed by Wang et al for hemodialysis patients exposed to aluminum-containing phosphate of either parent vitamin D (50 g/day) or 25-OHvitamin D 3 (5 g/day) for four to eight months [36] . They conbinder with a modest elevation of plasma aluminum (less than 2 mol/liter), as in our population [14] . There was cluded that the osteoid of patients with the osteomalacia of chronic renal failure did not appear to show any evino direct correlation between plasma PO 4 and plasma 25OHD, even in those with the highest levels of plasma dence of "resistance" to vitamin D. Clearly, the beneficial effect could have been a direct one of 25OHD (or vita-25OHD. There was a positive correlation between plasma Ca and plasma 25OHD; however, 8% of those min D 3 ), but there was the possibility that the increase in plasma level of 25OHD simply enabled the plasma with plasma 25OHD of less than 100 nmol/liter and 10% of those with plasma 25OHD above this level had a calcitriol to rise. In the hemodialysis patients reported here, the calcitriol levels were not significantly different plasma Ca of more than 2.70 mmol/liter. In six of the nine with hypercalcemia, plasma PTH was less than 10 in the three groups (58, 54, and 51 pmol/liter), which suggests that the protective effect at the bone level of pmol/liter (the lower limit of its optimal range), whereas it was well above the optimal limit of Wang et al in the higher plasma 25OHD levels was not mediated through calcitriol. Perhaps the most persuasive evidence that meother three patients (30 to 130 pmol/liter) [14] . Thus, there is no evidence that the higher plasma 25OHD tabolites of vitamin D other than calcitriol might act effectively on mineralization of bone is the knowledge levels were associated with higher plasma Ca or plasma PO 4 levels. that hemodialysis patients who are anephric for many years can have bones with no histological evidence of
We therefore recommend that all uremic patients, especially those on maintenance dialysis, have their plasma osteomalacia [37] .
These observations lead to the notion that 25OHD is 25-OHvitamin D periodically determined (especially at the end of the winter), and those having a level of less acting directly on bone mineralization. This idea is in keeping with two histomorphometrical studies in uremic than 100 nmol/liter (40 ng/ml) should have a vitamin D supplementation before considering therapy with 1␣-patients showing that for the same elevation of plasma calcium ϫ phosphate product (or even in the face of hydroxylated forms of vitamin D, which would increase the catabolism of 25-OHvitamin D [27] . To achieve this a falling product), 25-OHvitamin D 3 induced a greater extension of histological mineralization than either calgoal, we recommend a systematic oral supplement (especially from November to May in Western countries), cium carbonate with phosphate [38] or alphacalcidol [6] . The recent demonstration of the beneficial effect of rather than ultraviolet irradiation because of concerns about skin cancer [40] . Although the recommended daily 24,25-(OH) 2 D 3 in X-linked hypophosphatemic rickets/ osteomalacia [35] brings forth a further route by which supplement of parent vitamin D has recently been increased to 800 IU (20 g) in the general older population 25OHD might have a beneficial effect on the bone, because 25-OHvitamin D supplement is able to increase
[40], we would rather suggest that these uremic patients be given a double dose according to the recommendaplasma 24,25-(OH) 2 D 3 , as shown by Halloran et al [4] and our laboratory [39] .
tions of Cunningham and Makin [2] or use the 20 to 30 g/day dose of 25-OHvitamin D 3 according to our own Optimal vitamin D status in uremia and justification data [39] . Clearly, interventional studies are needed to for vitamin D supplementation in uremia define the highest safe level of plasma 25OHD that would adequately suppress PTH secretion without hyFrom our data, it appears that the patients with the lowest 25OHD levels are the ones that develop Looser's percalcemia and the optimal dosage and periodic intervals to administer the supplement, a daily administration zones. It is possible, therefore, that there is a threshold 
